Segment Results (Schedule Of Reportable Segments Information) (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($) segment	Jun. 30, 2016 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment			3
Segment Reporting Information [Line Items]
Total net revenues to external customers	$ 875,731	$ 920,887	$ 1,913,331	$ 1,884,426
Total segment adjusted income from continuing operations before income tax	396,273	358,003	882,246	760,306
U.S. Generic Pharmaceuticals
Segment Reporting Information [Line Items]
Total net revenues to external customers	563,312	565,358	1,285,295	1,148,748
Total segment adjusted income from continuing operations before income tax	253,866	214,968	595,465	426,736
U.S. Branded Pharmaceuticals
Segment Reporting Information [Line Items]
Total net revenues to external customers	245,188	288,342	495,347	597,155
Total segment adjusted income from continuing operations before income tax	127,595	122,420	257,087	291,201
International Pharmaceuticals
Segment Reporting Information [Line Items]
Total net revenues to external customers	67,231	67,187	132,689	138,523
Total segment adjusted income from continuing operations before income tax	$ 14,812	$ 20,615	$ 29,694	$ 42,369